Stocks to Watch Today: The Indian stock market is expected to start Thursday, September 25, on a weak note, with GIFT Nifty futures indicating a 39-point decline for the benchmark Nifty 50 index. Investors should brace for a volatile session as a mix of government policy moves, corporate deals, regulatory approvals, and strategic partnerships drive stock-specific action across key sectors of ₹24,736 crore. This landmark decision is expected to boost shipbuilding orders, create jobs, and attract private investment into the sector.
Glenmark Pharma: Signs Exclusive Cancer Drug Pact with Hengrui Pharma
Glenmark Pharmaceuticals will be in the spotlight after announcing that its subsidiary, Glenmark Speciality SA, has signed an exclusive licence and collaboration agreement with China’s Hengrui Pharma.
The deal covers the development and commercialization of trastuzumab rezetecan, a next-generation antibody-drug conjugate (ADC) designed to treat various forms of cancer. This collaboration marks a significant step in Glenmark’s oncology portfolio expansion and could become a major revenue driver if the drug progresses successfully through clinical trials and commercialization.
Akzo Nobel India: Global Investors Buy 5% Stake Worth ₹765 Crore
Shares of Akzo Nobel India, the Indian arm of global paints and coatings leader AkzoNobel, are expected to trade actively after Goldman Sachs, Morgan Stanley, and other institutional investors purchased a 5% stake worth ₹765 crore via a block deal on Wednesday.
Other major buyers include Citigroup Global Markets Mauritius, Nippon India MF, Edelweiss Life Insurance, Ward Ferry Management, Societe Generale, Mediolanum International Funds, and BNP Paribas Financial Markets. The strong interest from global institutional investors signals confidence in Akzo Nobel India’s growth prospects amid robust demand in the paints and coatings sector.
L&T and Bharat Electronics: Strategic Partnership for India’s AMCA Fighter Jet Program
Larsen & Toubro (L&T) and Bharat Electronics Ltd (BEL) shares are expected to be in focus after the two companies announced a strategic partnership to support the Advanced Medium Combat Aircraft (AMCA) program of the Indian Air Force (IAF).
The consortium will respond to the government’s Expression of Interest (EoI) for the AMCA project, combining L&T’s defence platform expertise with BEL’s experience in defence electronics. The collaboration aims to contribute to India’s ambitious 5th-generation fighter aircraft program, a critical milestone in strengthening the country’s indigenous defence manufacturing capabilities.
Read about: With Credit Monitoring, Rural India on the Verge of Unlocking Huge Economic Potential
Crisil: Acquires PriceMetrix to Expand Wealth Management Analytics
Crisil, an S&P Global company, announced the acquisition of McKinsey’s PriceMetrix Co., a Toronto-based leader in performance benchmarking and data analytics for wealth management firms in the US and Canada.
PriceMetrix’s proprietary database covers $8 trillion in assets under management (AUM) and 30 million investment accounts, providing valuable insights backed by 25 years of data. The acquisition will strengthen Crisil’s analytics portfolio with key products such as ValueOne, FeeCheck, CommissionCheck, and SignalOne.
Lupin: USFDA Approves Generic HIV Treatment Drug
Pharma major Lupin Ltd announced it has received tentative approval from the US FDA for its generic version of Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets — used in the treatment of HIV infection.
The approved formulation (50 mg/200 mg/25 mg) will be manufactured at Lupin’s Nagpur facility. This approval is expected to bolster Lupin’s US generics portfolio and provide a new revenue stream in the high-demand HIV treatment space.
Birla Corporation: Preferred Bidder for Telangana Limestone Block
Birla Corporation shares could see movement after its wholly owned subsidiary RCCPL Pvt Ltd was declared the preferred bidder for the Kanpa-Junapani Limestone Block by the Telangana Department of Mines & Geology. The block is expected to significantly enhance Birla’s raw material security and support its cement production expansion plans.
IPCA Laboratories: Signs Biosimilar Development Deal with BSS
IPCA Laboratories announced a technology transfer and joint development agreement with BioSimilar Sciences PR LLC (BSS), USA, for a next-generation monoclonal antibody biosimilar targeting cancer and autoimmune diseases.
The agreement involves transferring late-stage development, clinical manufacturing, and commercial supply operations to BSS’s facility in Puerto Rico, boosting IPCA’s presence in the global biosimilar market.
REC Ltd: Transfers Davanagere Power Transmission SPV to POWERGRID
REC Ltd said its subsidiary RECPDCL has transferred the Davanagere Power Transmission Ltd SPV to Power Grid Corporation of India Ltd under the Tariff-Based Competitive Bidding (TBCB) model.
POWERGRID won the bid to develop the transmission project on a Build, Own, Operate & Transfer (BOOT) basis. The project will be implemented over 24 months and is part of India’s efforts to enhance its national power grid infrastructure.
Polycab India: Promoters Launch ₹887 Crore Block Trade
Shares of Polycab India will be closely watched after reports suggested that promoter group members are planning to sell around 0.8% stake through a block trade worth approximately ₹887 crore ($100 million). The move is aimed at unlocking shareholder value and improving stock liquidity.
Newgen Software: Secures €4.22 Million Deal from TCS Belgium
Newgen Software Technologies announced that its UK subsidiary has received a €4.22 million order from Tata Consultancy Services N.V., Belgium. The contract covers cloud hosting, software licensing, and implementation services and is part of a master service agreement with TCS’s European subsidiary.